Regenerative medicine is a biological heterogeneous domain that incorporates material science, engineering, medicine, biological science, and surgery. It acts therapeutically by augmenting and stimulating the body’s capacity for regeneration and self-repair. Regenerative medicine involves the development of methods to regrow, repair or replace either the damaged or diseased cells, organs or tissues. This medicinal branch includes the generation and usage of stem cells and tissue engineering.
Moreover, Major players in the market are also focused on expanding their capabilities. For instance, in March 2020, BioStem Life Sciences, a subsidiary of BioStem Technologies Inc. and a developer of regenerative therapies, announced to add R&D laboratory to its Florida, U.S. facility.
Market Dynamics
Key companies focusing on product approvals in regenerative medicine is expected to drive the global regenerative medicine (Bone and Joint) market growth. For instance, in 2017, Karl Schumacher Dental, LLC launched its new range of regenerative products, which include allograft, xenograft, and synthetic and collagen membranes.
Moreover, adoption of 3D printing technology in regenerative medicine (bone and joint) is expected to aid in growth of the global regenerative medicine (bone and joint) market. For instance, in February 2020, researchers from Wake Forest School of Medicine, U.S. reported investigation of the effects of neural cell integration into the bioprinted skeletal muscle construct to accelerate functional muscle regeneration in vivo.
Furthermore, High prevalence of arthritis is expected to propel growth of the global regenerative medicine (bone and joint) market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, around 54.4 million U.S. adults had diagnosed arthritis, which accounted for around 1 in 4 people in the U.S.
Key features of the study:
- This report provides in-depth analysis of the global regenerative medicine (bone and joint) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
- It profiles leading players in the global regenerative medicine (bone and joint) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
- The global regenerative medicine (bone and joint) market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
- The key players operating in global regenerative medicine (Bone and Joint) market include Anika Therapeutics, Inc, Arthrex, Inc., Baxter International, Inc., CONMED Corporation, Johnson & Johnson, Medtronic, Plc, Smith & Nephew plc, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc.
- Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global regenerative medicine (bone and joint) market
Detailed Segmentation:
- Global Regenerative Medicine (Bone and Joint) Market, By Technology :
- Stem Cell
- Biomaterial
- Tissue Engineering
- Global Regenerative Medicine (Bone and Joint) Market, By Application :
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
- Global Regenerative Medicine (Bone and Joint) Market, By Region:
- By Technology:
- Stem Cell
- Biomaterial
- Tissue Engineering
- By Application :
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
- By Country:
- By Technology:
- Stem Cell
- Biomaterial
- Tissue Engineering
- By Application :
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Technology:
- Stem Cell
- Biomaterial
- Tissue Engineering
- By Application :
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Technology:
- Stem Cell
- Biomaterial
- Tissue Engineering
- By Application :
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Technology:
- Stem Cell
- Biomaterial
- Tissue Engineering
- By Application :
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
- By Country/Region:
- GCC
- Israel
- Rest of Middle East
- By Technology:
- Stem Cell
- Biomaterial
- Tissue Engineering
- By Application :
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Anika Therapeutics, Inc.*
- Arthrex, Inc.
- Baxter International, Inc.
- CONMED Corporation
- Johnson & Johnson
- Medtronic, Plc
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Holdings, Inc.
- Aziyo Biologics
- Ortho Regenerative Technologies Inc
“*” marked represents similar segmentation in other categories in the respective section.
